Navigation Links
Government Relations CEO Joins MedeFile Advisory Board

BOCA RATON, Fla., Feb. 18 /PRNewswire-FirstCall/ -- MedeFile International, Inc. (OTC Bulletin Board: MDFI), leader in portable electronic medical records management, announced today the addition of Mr. Thomas P. O'Neill III to its Board of Advisors.

CEO of Boston-based O'Neill and Associates, Mr. O'Neill oversees client servicing and supervises all aspects of the highly respected and vastly influential government relations and communications firm. He directs the strategic planning and management of the company's overall marketing efforts, long-term growth and new business opportunities.  Formerly president of McDermott/O'Neill & Associates, another top government relations and communications consulting firm, as well as Washington, D.C.-based PR firm FH/GPC, Mr. O'Neill said, "I'm truly excited about the innovations that MedeFile has introduced into the emerging field of Personal Health Records. With their attention to patients' care and commitment to integrity, MedeFile is unique in the world of personal medical records management."  

Prior to forming McDermott/O'Neill, Mr. O'Neill served as president of Bay State Investors, utilizing his 13 years of government experience to advise clients on all aspects of government relations at the local, state and federal levels. A former Lieutenant Governor of Massachusetts and highly-respected member of New England's health care community," Mr. O'Neill added, "with healthcare reform at the forefront of the national debate, and MedeFile at the forefront of modernized healthcare, I look forward to my role in advising MedeFile on healthcare issues and contributing to the continued growth and success of the company."

Mr. O'Neill currently sits on the board of trustees of Boston College and on the board of directors of CareGroup, Inc., New England's second largest health care service provider. He also serves on the boards of Mount Auburn Hospital and the Bunker Hill Community College Foundation.  Mr. O'Neill received his bachelor's degree from Boston College and earned his masters in public administration from Harvard University's John F. Kennedy School of Government.

Milton Hauser, CEO of MedeFile said, "Tom O'Neill's vast experience working at the convergence point of healthcare and government makes him an invaluable advocate for Personal Health Records (PHR's) in both the municipal and private sectors." Mr. Hauser added, "In our ongoing commitment to affect positive changes in nationwide healthcare, we will continue to take bold steps to ensure MedeFile's continued growth and maintain our distinction as a leader in electronic personal health records."

About MedeFile International, Inc.

Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week.  For more information about MedeFile and its annual subscription-based programs, please visit

Safe Harbor Statement Under the Private Securities Litigation Act of 1995

With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.

Contact: +1-561-912-3393 ext. 155,

SOURCE MedeFile International, Inc.



SOURCE MedeFile International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
2. Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government
3. Malaria Experts Call on Federal Government to Increase Support for Research and Development
4. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
5. BioCryst Clarifies Government Declaration Regarding Peramivir
6. Southern Research to Play Key Role in the Federal Governments Search for New Cancer Therapies
7. One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak
8. The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Countrys Biological Preparedness
9. Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
Post Your Comments:
(Date:11/24/2015)... Avery Biomedical Devices (ABD), manufacturer of the ... appointment of Anders Jonzon , MD; Ph.D. as ... Dr. Jonzon is a Physiologist and consultant ... University, Uppsala and Children,s Hospital, Karolinska, Stockholm, ... at the Cardiovascular Institute (UCSF). His research has covered ...
(Date:11/24/2015)... LAUSANNE and BERN, Switzerland ... SA, the ARTORG Center for Biomedical Engineering Research of ... and the Division of Endocrinology, Diabetes and Clinical Nutrition ... announce the start of an exclusive collaboration to develop ... control algorithm for the personalised delivery of insulin for ...
(Date:11/24/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... Education and Human Resources will be presenting in the upcoming ... Plan Strategies for a Dynamic Market" on Dec. 1, 2015. ... consultant with the Cambridge Advisory Group, where she leads their ... The webinar will discuss the rapid growth of oral oncolytics, ...
Breaking Medicine Technology:
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Dr. Rodney E. Willey , has ... new venture, Koala Center for Sleep Disorders, provides treatment for snoring and sleep apnea ... have opened a Koala Center for Sleep Disorders in the US, one of four in ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... and Healthy Aging Program have announced their endorsement of the Medical Fitness ... Health Fitness is proud to have the MFN as one of our endorsed ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Autism Speaks, the ... global movement driven by social media and the generosity of people around the world. ... their social media networks to give – and share the personal stories behind those ...
(Date:11/24/2015)... Miami, FL (PRWEB) , ... November 24, 2015 ... ... manufacturer and engineer of patented products, announces Innovative Blending, a household invention that ... go. , "The Juice & Smoothie Bars market is worth $2 billion," says ...
(Date:11/24/2015)... ... November 24, 2015 , ... Robert Yeager CEO of PharmMD, has ... past year there have been multiple breakthroughs and challenges as healthcare reform moves out ... enabled their customers and partners to stay ahead of the curve by breaking down ...
Breaking Medicine News(10 mins):